University lecturer Israr Jan-Parker has raised £8,500 for Brain Tumour Research.
Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results